Black men are more likely to report decisional regret over localized prostate cancer (PCa) treatment than men of other races, according to new study findings.
Investigators analyzed survey responses from 146 (38.73%) Black patients and 231 (61.27%) non-Black patients matched by PCa pathology, age, treatment type, and other factors from the Cleveland Clinic. All patients answered 4 surveys, including a novel Prostate Cancer Beliefs Questionnaire (PCBQ), the Decisional Regret Scale, the Expanded Prostate Cancer Index Composite (EPIC) 26, and a modified EPIC demographics form.